Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. LH
LH logo

LH News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

LH News

Labcorp to Release Q2 2026 Financial Results on July 30

Jun 30 2026PRnewswire

Labcorp Launches First RNA-Based At-Home Colorectal Cancer Screening Test

Jun 22 2026PRnewswire

Labcorp Launches First FDA-Approved At-Home Screening Test for Colorectal Cancer

Jun 22 2026Newsfilter

Labcorp Partners with Alliance for Clinical Trials on Colorectal Cancer Study

May 29 2026NASDAQ.COM

Labcorp Partners with Alliance for Clinical Trials to Enhance Genetic Testing in Colorectal Cancer

May 29 2026PRnewswire

Labcorp Partners with Alliance for Clinical Trials to Enhance Genetic Testing in Colorectal Cancer

May 29 2026Newsfilter

Labcorp Partners with Alliance for Clinical Trials to Expand Genetic Testing in Colorectal Cancer

May 29 2026Yahoo Finance

Labcorp Launches New DPYD Genotyping Test for Cancer Patients

May 28 2026PRnewswire

LH Events

06/22 07:30
Labcorp Launches FDA-Approved ColoSense Colorectal Cancer Screening Test
Labcorp announced the nationwide availability of ColoSense, the only RNA-based at-home test for colorectal cancer screening approved by the U.S. FDA. Offered through a commercial collaboration with test developer Geneoscopy, ColoSense expands Labcorp's comprehensive portfolio of colorectal cancer screening solutions. The test is now covered for eligible Medicare and Medicare Advantage beneficiariesi following the Centers for Medicare & Medicaid Services update to the National Coverage Determination in June, with additional commercial coverage also available.
05/29 07:20
Labcorp Collaborates with Alliance for Clinical Trials to Advance Colorectal Cancer Clinical Trial
Labcorp announced a collaboration with the Alliance for Clinical Trials in Oncology to advance a national, multicenter clinical trial for patients newly diagnosed with colorectal cancer. The trial will evaluate approaches to increase germline genetic testing among at-risk family members, as well as the impact of multigene panel testing on care for newly diagnosed patients. Leveraging its Invitae testing, Labcorp will serve as the exclusive genetic testing provider, supporting participating sites with its national scale and scientific expertise.
05/21 16:30
Illumina Appoints David King to Board of Directors
Illumina (ILMN) confirmed the election of David King to its Board of Directors, effective immediately following the company's annual meeting of shareholders. King's election marks an important addition to Illumina's Board as the company accelerates its clinical strategy to integrate genomics more broadly into the standard of care. . King is the former Executive Chairman and Chief Executive Officer of Labcorp (LH).
05/12 07:10
Labcorp Expands Collaboration with Epic
Labcorp announced an expanded collaboration with Epic, the nation's leading electronic health record supporting hospitals and health systems. Through the collaboration, Labcorp's full test menu will be available through Aura, Epic's unified platform for ordering and receiving lab results. The integration will drive meaningful operational efficiencies, streamline lab ordering for clinicians and care teams, and improve access to diagnostic innovation for hospitals and health systems using Epic nationwide.

LH Monitor News

Labcorp Declares $0.72 Quarterly Dividend, Attracting Income Investors

Apr 10 2026

Labcorp Reports Q4 Earnings Beat and Positive 2026 Outlook

Feb 17 2026

Labcorp Appoints Dr. John H. Sampson to Board

Feb 10 2026

LH Earnings Analysis

Labcorp Holdings Inc Earnings: Growth Driven by Acquisitions- Intellectia AI™
8 months ago

People Also Watch